Kyeong Kyu
Kyeong Kyu Kim, Gyeonggi-Do KR
Patent application number | Description | Published |
---|---|---|
20090075308 | Method for in vitro phosphorylation of TRAP of Staphylococcus aureus and a method for screening the inhibitor of the TRAP phosphorylation - The present invention relates to a method for in vitro phosphorylation of TRAP derived from | 03-19-2009 |
Kyeong Kyu Kim, Seoul KR
Patent application number | Description | Published |
---|---|---|
20130143856 | NOVEL ANTIBIOTIC COMPOSITION COMPRISING FLUFENAMIC ACID AS AN ACTIVE INGREDIENT - The present invention relates to a novel antibiotic, and more specifically relates to an antibiotic composition comprising flufenamic acid as an active ingredient, which can reduce drug toxicity and side effects and the problem of antibiotic resistance caused by excessive use of antibiotics since the composition exhibits a good therapeutic effect, even in a small dose, when it is administered either alone or together with another antibiotic of the prior art. | 06-06-2013 |
Kyeong Kyu Kim, Suwon-Si KR
Patent application number | Description | Published |
---|---|---|
20140371143 | NEW PEPTIDE INHIBITING RANKL-RANK INTERACTION AND THE USE THEREOF - Provided are a peptide for inhibiting an interaction between an RANKL and an RANK consisting of an amino acid sequence of SEQ ID NO: 1 and a pharmaceutical composition for preventing or treating bone diseases including the peptide. The peptide consisting of an amino acid sequence of SEQ ID NO: 1 is not present in a cyclic shape, and has 10 or less amino acids, thereby having better biostability than a conventional peptide to inhibit an RANKL-RANK interaction, being preferable in price during synthesis, and having a better RANKL-RANK interaction inhibitory effect. For this reason, the peptide may be used as an effective component of the composition effectively inhibiting differentiation of osteoclasts. A pharmaceutical composition including the peptide is bound with the RANKL and the peptide, instead of the RANK, thereby inhibiting the interaction between the RANKL and the RANK, and thus inhibiting osteoclast differentiation. | 12-18-2014 |